Drugs

Patients and their providers increasingly face limited or nonexistent supplies of drugs, many of which treat conditions such as cancer, heart disease and bacterial infections. But why?

Ocular pain, blurred vision, photosensitivity, hyperemia and other ocular symptoms may begin two to four days after the bisphosphonate infusion.

Doctors need to fight the inertia that can result from software programs providing a full list of DDIs—some of which aren't clinically significant.

Health Canada has conditionally approved Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone.

Can you find the false statement?

But tough sorting out how much is related to reducing disease symptoms.

Last year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.

Eli Lilly and Co. is seeking U.S. Food and Drug Administration approval of donanemab. If cleared, it would be only the second Alzheimer’s treatment convincingly shown to delay the mind-robbing disease—after the recently approved Leqembi from Japanese drugmaker Eisai.

The manufacturer, Ireland-based Perrigo, won’t start shipping the pill until early next year, and there will be no age restrictions on sales.

A review of new launches, new indications, new dosage forms and Health Canada advisories.